We recently compiled a list of the 11 Most Expensive Stocks Insiders Are Buying Recently. In this article, we are going to ...
Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the ...
Tectonic Therapeutic, Inc. (NASDAQ: TECX) has announced a significant $185 million private placement financing. The private investment in public equity financing (PIPE) is expected to result in gross ...
Shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) gapped up prior to trading on Monday following insider buying activity. The stock had previously closed at $36.45, but opened at $39.98.
Timothy A. Springer, a director and ten percent owner of Tectonic Therapeutic, Inc. (NASDAQ:TECX), has significantly increased his stake in the company through recent stock purchases. According to a ...
Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Tectonic Therapeutic, Inc. before investing. In this article, we go over a few ...
This week’s Boston biotech roundup is driven by funding news. Tectonic Therapeutic secured a $185 million private placement, Curie.Bio has landed a new seed fund and Airna is hiring a chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results